This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Willigers, H. M. Articles by Durieux, M. E. Search for Related Content PubMed PubMed Citation Articles by Willigers, H. M. Articles by Durieux, M. E. Related Collections Cardiovascular Heart Pharmacology

---

CARDIOVASCULAR ANESTHESIA

Dexmedetomidine Decreases Perioperative Myocardial Lactate Release in Dogs

Henriëtte M. Willigers, MD^*, Frits W. Prinzen, PhD, Paul M. Roekaerts, MD PhD^*, Simon de Lange, MB BS, PhD, FRCA^*, and Marcel E. Durieux, MD PhD^*

*Department of Anesthesiology, University Hospital Maastricht; and Department of Physiology, Maastricht University, Maastricht, The Netherlands

Address correspondence to Henriëtte Willigers, Department of Anesthesiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Address e-mail to hwil{at}sane.azm.nl Reprints will not be available from the author.

The sympatholytic effect of the ₂-adrenergic agonist dexmedetomidine may decrease emergence-related myocardial ischemic load in patients. However, a direct measure of myocardial ischemia, such as myocardial lactate release, is difficult to obtain in patients. Therefore, we studied mongrel dogs and measured myocardial lactate release, myocardial oxygen supply, hemodynamic variables, and neurohumoral indices of the stress response. After the induction of a standardized degree of borderline myocardial ischemia, either dexmedetomidine (dexmed group, n = 9) or normal saline (control group, n = 9) was infused. Measurements were repeated at the end of the anesthetic period and every 10 min during the 90-min emergence period. In the dexmed group, the cumulative emergence-related lactate release was 46% less than in the control group (95% confidence interval, 20%–80%; P = 0.02). Simultaneously, dexmedetomidine increased the endo-/epicardial blood flow ratio by 35% (control group, 0.4 ± 0.1; dexmed group, 0.6 ± 0.1; P = 0.03). These antiischemic effects of dexmedetomidine were accompanied by reduced plasma concentrations of norepinephrine (126 versus 577 pg/mL) and epinephrine (158 versus 1909 pg/mL) and a slower heart rate (123 ± 6 versus 160 ± 10 bpm, dexmed versus control). The antiischemic effect of dexmedetomidine started before emergence, as evidenced by a decreased prevalence of myocardial lactate release at that time (zero of eight dogs in the dexmed group and four of seven dogs in the control group had lactate release before emergence; P = 0.03).

IMPLICATIONS: Dexmedetomidine decreases plasma catecholamines and heart rate during emergence from anesthesia. In dogs with a coronary stenosis, these sympatholytic effects decrease myocardial lactate release and, therefore, minimize emergence-related myocardial ischemia.

This article has been cited by other articles:

				M. W. Dunser and W. R. Hasibeder Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress J Intensive Care Med, September 1, 2009; 24(5): 293 - 316. [Abstract] [PDF]

				H. Guo, S. Takahashi, S. Cho, T. Hara, S. Tomiyasu, and K. Sumikawa The Effects of Dexmedetomidine on Left Ventricular Function During Hypoxia and Reoxygenation in Isolated Rat Hearts Anesth. Analg., March 1, 2005; 100(3): 629 - 635. [Abstract] [Full Text] [PDF]